Oropharyngeal Candida Colonization in Patients with Acute Myeloid Leukemia
,
Abstract
Objectives: Oral candidiasis has increased in recent years because of the increasing number of high-risk populations. The prevalence of Candida species is different worldwide because of the difference between population characteristics, sampling protocols, and geographic regions. Therefore, determining the more prevalent Candida species in different geographic regions seems essential. This study aimed to determine the more prevalent Candida species in acute myeloid leukemia (AML) patients in comparison with healthy individuals in Iran in 2016.
Materials and Methods: Fifty-one patients with AML and 62 healthy controls participated in this cross-sectional study. Samples were collected using a swab rubbed softly on the dorsal surface of the tongue and the oropharynx. The samples were cultured on CHROMagar Candida for 2 to 4 days. For differentiation between albicans and non-albicans species, positive samples were linearly inoculated on Corn Meal Agar with Tween-80. Candida species were identified using a microscope. Data were analyzed using chi-square and Fisher’s exact tests.
Results: Candida colonization was more frequent in AML patients (41.2%) in comparison with healthy participants (38.7%). Candida glabrata (C. glabrata; 27.5%) and Candida albicans (C. albicans; 32.3%) were the most common isolated species in the AML patients and the controls, respectively. There was a significant decrease in the frequency of C. albicans (P=0.022) and a significant increase in the frequency of C. glabrata (P=0.002) in the AML patients in comparison with the controls.
Conclusion: AML patients are more susceptible to candidiasis. C. glabrata is the dominant Candida species in AML patients.
2. Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014 Feb 13;10:95-105.
3. Dongari‐Bagtzoglou A, Dwivedi P, Ioannidou E, Shaqman M, Hull D, Burleson J. Oral Candida infection and colonization in solid organ transplant recipients. Oral Microbiol Immunol. 2009 Jun;24(3):249-54.
4. Al-Attas SA, Amro SO. Candidal colonization, strain diversity, and antifungal susceptibility among adult diabetic patients. Ann Saudi Med. 2010 Mar-Apr;30(2):101-8.
5. Gullo A. Invasive fungal infections: the challenge continues. Drugs. 2009;69 Suppl 1:65-73.
6. Bensadoun RJ, Patton LL, Lalla RV, Epstein JB. Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer. 2011 Jun;19(6):737-44
Tanaka T, Okutomi T, Wakabayashi H, Ishibashi H, Tansho S, Ninomiya K, et al. Condition for effective inhibition of Candida albicans growth by lactoferricin B and its therapeutic activity with fluconazole against oral candidiasis in mice. Med Mycol Res. 2011;2(1):33-41.
8. Sun H, Chen Y, Zou X, Li H, Yin X, Qin H, et al. Occurrence of oral Candida colonization and its risk factors among patients with malignancies in China. Clin Oral Investig. 2016 Apr;20(3):459-67.
9. Bagg J, Sweeney MP, Lewis MA, Jackson MS, Coleman D, Al MA, et al. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med. 2003 Sep;17(6):477-81.
10. Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002 Apr;50(4):243-60.
11. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis. 1995 Jan;20(1):115-25.
12. Perfect JR, Hachem R, Wingard JR. Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients. Clin Infect Dis. 2014 Nov 15;59 Suppl 5:S352-5.
13. Ellepola AN, Morrison CJ. Laboratory diagnosis of invasive candidiasis. J Microbiol. 2005 Feb;43 Spec No:65-84.
14. Inaba H, Gaur AH, Cao X, Flynn PM, Pounds SB, Avutu V, et al. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia. Cancer. 2014 Jul 1;120(13):1985-92.
15. Wu CJ, Lee HC, Yang YL, Chang CM, Chen HT, Lin CC, et al. Oropharyngeal yeast colonization in HIV‐infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter. Clin Microbiol Infect. 2012 May;18(5):485-90.
16. Sánchez-Vargas LO, Ortiz-López NG, Villar M, Moragues MD, Aguirre JM, Cashat-Cruz M, et al. Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico. J Clin Microbiol. 2005 Aug;43(8):4159-62.
17. Khubnani H, Sivarajan K, Khubnani AH. Application of lactophenol cotton blue for identification and preservation of intestinal parasites in faecal wet mounts. Indian J Pathol Microbiol. 1998 Apr;41(2):157-62.
18. Fidel PL Jr, Vazquez JA, Sobel JD. Candidaglabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999 Jan;12(1):80-96.
19. Dongari-Bagtzoglou A, Fidel PL Jr. The host cytokine responses and protective immunity in oropharyngeal candidiasis. J Dent Res. 2005 Nov;84(11):966-77.
20. Torres SR, Peixoto CB, Caldas DM, Akiti T, Barreiros MG, de Uzeda M, et al. A prospective randomized trial to reduce oral Candida spp. colonization in patients with hyposalivation. Braz Oral Res. 2007 Apr-Jun;21(2):182-7.
21. Agarwal V, Joyce M. Microbiologically documented fungal infections in pediatric patients with acute myeloid leukemia: 12.5-year experience at a single institution. J Pediatr Hematol Oncol. 2014 Nov;36(8):e528-32.
22. Dufresne SF, Marr KA, Sydnor E, Staab JF, Karp JE, Lu K, et al. Epidemiology of Candida kefyr in patients with hematologic malignancies. J Clin Microbiol. 2014 Jun;52(6):1830-7.
23. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review. Int J Infect Dis. 2010 Nov;14(11):e954-66.
24. Martin D, Persat F, Piens MA, Picot S. Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001. Eur J Clin Microbiol Infect Dis. 2005 May;24(5):329-33.
25. Epstein JB, Freilich MM, Le ND. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck. Oral Surg Oral Med Oral Pathol. 1993 Aug;76(2):169-74.
26. Yang YL, Leaw SN, Wang AH, Chen HT, Cheng WT, Lo HJ. Characterization of yeasts colonizing in healthy individuals. Med Mycol. 2011 Jan;49(1):103-6.
| Files | ||
| Issue | Vol 17 (Continuously Published Article-Based) | |
| Section | Original Article | |
| DOI | https://doi.org/10.18502/fid.v17i1.3966 | |
| Keywords | ||
| Acute Myeloid Leukemia Candida Oral Candidiasis Oropharynx | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
